Stock Quote, Chart, News

Symbol Company Name Latest Time Prev Close Latest Price Change $ Change % 52 Wk High 52 Wk Low YTD Chg% Volume
SUPNSupernus PharmaceuticalsDecember 10, 201837.9137.911.383.7861.2534.9-2.5941554


Supernus Succeeds In Phase 3, But Could Face An Uphill Battle

2018-12-07 10:54

Recently, Supernus ( SUPN ) announced results from two phase 3 studies treating patients with ADHD using SPN-812. Both studies met the primary endpoint; however, the drug didn't end up being superior to generic alternatives in terms of efficacy. There are still two positives from these s…... by SeekingAlpha


Sector: Healthcare

Industry: Drug Manufacturers

Description: Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

©, All Right Reversed.

Market data provided by IEX Group Inc. The information provided by is not investment advice. Trading and investing in financial markets involves risk. You are responsible for your own investment decisions.

New stock charting and analyzer software coming soon, please stay tuned, if you want to go to old site, click Here.